Kliniska studier för KOL i Florida
28 studier för KOL söker deltagare vid platser i Florida.
Städer i Florida
- Miami18 studier
- Orlando15 studier
- Hialeah8 studier
- Tampa7 studier
- Kendall7 studier
- Jacksonville6 studier
- West Palm Beach6 studier
- Ocala5 studier
- Doral4 studier
- Deltona4 studier
- St. Petersburg4 studier
- Boca Raton4 studier
- Cape Coral3 studier
- Brandon3 studier
- Plantation3 studier
- Palm Coast3 studier
- Naples3 studier
- Clearwater3 studier
Officiell studietext (engelska)
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Meris Clinical Research- Site Number : 8400153, Brandon
- Hillcrest Medical Research- Site Number : 8400082, DeLand
- Finlay Medical Research - Greenacres- Site Number : 8400107, Greenacres City
- och 18 fler
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 1 okt. 2026 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- International Clinical Research, Altamonte Springs
- Nature Coast Clinical Research, Crystal River
- Clinical Site Partners, LLC Leesburg dba Flourish Research, Leesburg
- och 2 fler
RekryterarFas 2
Ålder 40 till 85 · Alla kön · Uppdaterad 30 sep. 2026 · NCT07684820A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Millennium Medical Research - Miami, Miami
- Deluxe Health Center, Miami Lakes
- Florida Institute For Clinical Research, LLC, Orlando
RekryterarFas 2
Ålder 40 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07759245A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
- GSK Investigational Site, Miami
- GSK Investigational Site, Tampa
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07780656A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- University of Miami Dermatology Clinical Trials Unit- Site Number : 8400015, Miami
- Finlay Medical Research- Site Number : 8400010, Miami
RekryterarFas 4
Ålder 40 till 85 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07053423Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Helix Biomedics- Site Number : 8400065, Boynton Beach
- Beautiful Minds Clinical Research Center- Site Number : 8400017, Cutler Bay
- Eastern Medical Group Research- Site Number : 8400020, Fort Myers
- och 10 fler
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07190209A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)
- Helix Biomedics- Site Number : 8403065, Boynton Beach
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 21 sep. 2026 · NCT07793409An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Orlando Health, Orlando
Rekryterar
Ålder 40 till 80 · Alla kön · Uppdaterad 17 sep. 2026 · NCT06035120A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, Miami Lakes
RekryterarFas 2
Ålder 40 till 80 · Alla kön · Uppdaterad 15 sep. 2026 · NCT07646587A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Brandon
- Research Site, Cape Coral
- Research Site, Clearwater
- och 17 fler
RekryterarFas 2
Ålder 40 och äldre · Alla kön · Uppdaterad 9 sep. 2026 · NCT07082738A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
- GSK Investigational Site, Doral
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 9 sep. 2026 · NCT07780669Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Florida, Jacksonville
RekryterarFas 2
Ålder 40 och äldre · Alla kön · Uppdaterad 4 sep. 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Bay Pines
- Research Site, Boynton Beach
- Research Site, Jacksonville
- och 5 fler
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 3 sep. 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Clearwater
- Research Site, Cutler Bay
- Research Site, Cutler Bay
- och 9 fler
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 3 sep. 2026 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Finlay Medical Research, Greenacres City
- Clinical Research Specialists LLC, Kissimmee
- Advanced Pulmonary Research Institute, Loxahatchee Groves
- och 9 fler
RekryterarFas 2/3
Ålder 35 till 80 · Alla kön · Uppdaterad 31 aug. 2026 · NCT07363694Rademikibart IV for Acute Asthma and COPD Exacerbation
- Columbus Clinical Services, LLC, Miami
- Pharmax Research of South Florida, Inc., Miami
RekryterarFas 2
Ålder 18 till 85 · Alla kön · Uppdaterad 27 aug. 2026 · NCT07705737A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Boynton Beach
- Research Site, Bradenton
- Research Site, Cape Coral
- och 25 fler
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 26 aug. 2026 · NCT06283966Alpha-1 Research Registry
- Alpha-1 Foundation, Coral Gables
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 19 aug. 2026 · NCT04157049A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 103, Gainesville
- GC2501 Study Site 105, Miami
RekryterarFas 3
Ålder 18 till 80 · Alla kön · Uppdaterad 11 aug. 2026 · NCT07555483STRIVE Post-Market Registry Study
- University of Miami, Coral Gables
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 3 aug. 2026 · NCT04302272eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Brandon
- GSK Investigational Site, Crystal River
- GSK Investigational Site, Doral
- och 8 fler
RekryterarFas 3
Ålder 40 till 75 · Alla kön · Uppdaterad 28 juli 2026 · NCT07177339Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD
- University of Miami, Miami
Rekryterar
Ålder 18 till 100 · Alla kön · Uppdaterad 22 juni 2026 · NCT06578156Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Mayo Clinic Jacksonville, Jacksonville
Rekryterar
Ålder 40 till 80 · Alla kön · Uppdaterad 28 apr. 2026 · NCT07051707Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Mayo Clinic, Jacksonville
- Orlando Health, Orlando
Rekryterar
Ålder 40 till 84 · Alla kön · Uppdaterad 24 apr. 2026 · NCT06891755Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Brooksville
- GSK Investigational Site, Doral
- GSK Investigational Site, Fort Lauderdale
- och 15 fler
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 9 apr. 2026 · NCT06961214Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
- GSK Investigational Site, Loxahatchee Groves
- GSK Investigational Site, Miami
RekryterarFas 3
Ålder 40 till 80 · Alla kön · Uppdaterad 8 okt. 2025 · NCT06959095Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Hillcrest Medical Research, DeLand
- Universal Axon Clinical Research, Doral
- I.H.S Health, LLC, Kissimmee
- och 3 fler
RekryterarObservationsstudie
Ålder 50 och äldre · Alla kön · Uppdaterad 5 aug. 2025 · NCT06122077myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- University of Florida, Jacksonville, Jacksonville
- Alloy Clinical Research, Kissimmee
- Reliable Research, Inc., Miami
- och 2 fler
Rekryterar
Ålder 30 och äldre · Alla kön · Uppdaterad 6 feb. 2025 · NCT05204888Från ClinicalTrials.gov, data hämtad 2 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.